Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 236 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-04-26 | 2024-04-26 | 226348 |
| APO-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226345 |
| APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226342 |
| APO-FOSINOPRIL | 10MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226339 |
| APO-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226336 |
| APO-MIRTAZAPINE | 45MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226333 |
| APO-TERAZOSIN | 2MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226330 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226327 |
| APO-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226324 |
| APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226321 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2024-04-26 | 2024-04-26 | 226318 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226315 |
| APO-CITALOPRAM | 20MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226312 |
| APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-04-26 | 2024-04-26 | 226309 |
| APO-LITHIUM CARBONATE | 150MG | CAPSULE | Actual shortage | 2024-04-19 | 2024-04-19 | 225802 |
| APO-GLICLAZIDE | 80MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225799 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Actual shortage | 2024-04-19 | 2024-04-26 | 225796 |
| APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-19 | 2024-04-26 | 225793 |
| APO-TADALAFIL | 10MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-26 | 225790 |
| APO-TADALAFIL PAH | 20MG | TABLET | Actual shortage | 2024-04-19 | 2024-04-19 | 225785 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |